Psychiatry and Neurology, Neurology · Rego Park, NY
NPI
1861422859
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9952 66th Rd, Lobby C
Rego Park, NY, 11374
Phone (718) 459-2848
Groups this clinician bills Medicare through
Medicare paid, 2024
$247K
3,561 services
Medicare patients, 2024
516
Average age 77
Drug cost, 2024
$1.2M
3,479 prescriptions
Company payments, 2025
$479
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vladimir Zlatnik was code 99213 (office e&m - established), 513 times for 316 patients. In total Vladimir Zlatnik billed 3,561 services in 35 codes, and Medicare paid $247K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 513 | 316 | $73.02 | $37K |
| 20610 Joint Injection | Office | 394 | 150 | $60.33 | $24K |
| 95886 Electrical Nerve Conductivity | Office | 342 | 163 | $78.10 | $27K |
| 99212 Office E&M - Established | Office | 310 | 185 | $45.88 | $14K |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 259 | 39 | $57.88 | $15K |
| 77002 Imaging - Miscellaneous | Office | 251 | 86 | $97.08 | $24K |
| 99204 Office E&M - New | Office | 195 | 195 | $133.42 | $26K |
| 95910 Electrical Nerve Conductivity | Office | 171 | 163 | $143.03 | $24K |
| 27096 Joint Injection | Office | 65 | 52 | $139.04 | $9,038 |
| 20552 Musculoskeletal | Office | 64 | 43 | $43.22 | $2,766 |
| 20551 Musculoskeletal | Office | 52 | 39 | $46.32 | $2,409 |
| 95816 Neurologic | Office | 46 | 46 | $330.13 | $15K |
| 99441 Telephone Services | Office | 46 | 39 | $42.15 | $1,939 |
| 62323 Nerve Block Injection - Back | Office | 40 | 29 | $213.96 | $8,558 |
| 64420 Musculoskeletal | Office | 36 | 30 | $80.40 | $2,894 |
By year: 2022 $357K for 7,351 services; 2023 $305K for 4,590 services; 2024 $247K for 3,561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vladimir Zlatnik prescribed most often to Medicare patients was Diclofenac Sodium, with 382 prescriptions and refills. In total Vladimir Zlatnik wrote 3,479 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 382 | 388 | 73 | $244K |
| Duloxetine Hcl Generic | 357 | 375 | 80 | $2,465 |
| Meloxicam Generic | 253 | 254 | 161 | $738 |
| Gabapentin Generic | 206 | 209 | 81 | $680 |
| Pregabalin Generic | 195 | 198 | 60 | $1,416 |
| Tizanidine Hcl Generic | 171 | 175 | 105 | $596 |
| Ztlido Lidocaine | 114 | 121 | 23 | $62K |
| Dihydroergotamine Mesylate Generic | 103 | 103 | 14 | $119K |
| Tramadol Hcl Generic | 102 | 102 | 46 | $223 |
| Memantine Hcl Generic | 99 | 99 | 39 | $1,143 |
| Rivastigmine Generic | 94 | 95 | 34 | $9,385 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 85 | 85 | 46 | $436 |
| Ubrelvy Ubrogepant | 78 | 80 | 12 | $124K |
| Quetiapine Fumarate Generic | 76 | 76 | 19 | $577 |
| Qulipta Atogepant | 75 | 77 | 13 | $77K |
Brand drugs: 699 claims; generic drugs: 2,780 claims; opioid claims: 203.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vladimir Zlatnik $479 ($479 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.